Keratinocyte derived interferon
    6.
    发明授权
    Keratinocyte derived interferon 失效
    角质细胞来源的干扰素

    公开(公告)号:US06433145B1

    公开(公告)日:2002-08-13

    申请号:US09487792

    申请日:2000-01-20

    IPC分类号: C07K1700

    摘要: The present invention relates to a novel KDI protein which is a member of the interferon family. In particular, isolated nucleic acid molecules are provided encoding a human interferon polypeptide, called “KDI”. KDI polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of KDI activity. Also provided are therapeutic methods for treating immune system-related disorders.

    摘要翻译: 本发明涉及作为干扰素家族成员的新型KDI蛋白。 特别地,提供编码人干扰素多肽的分离的核酸分子,称为“KDI”。 还提供KDI多肽,载体,宿主细胞以及用于制备其的重组方法。 本发明还涉及用于鉴定KDI活性的激动剂和拮抗剂的筛选方法。 还提供了治疗免疫系统相关疾病的治疗方法。